BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med 2021;10:959. [PMID: 33804464 DOI: 10.3390/jcm10050959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zhang R, Ma J, Tang S, Li Y, Li Y, Wan J. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth. Front Microbiol 2021;12:710940. [PMID: 34421869 DOI: 10.3389/fmicb.2021.710940] [Reference Citation Analysis]
2 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]
3 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
4 Sung JJY, Wong SH. What is unknown in using microbiota as a therapeutic? J Gastroenterol Hepatol 2021. [PMID: 34668228 DOI: 10.1111/jgh.15716] [Reference Citation Analysis]
5 Gao Y, Liu L, Li C, Liang Y, Lv J, Yang L, Zhao B. Study on the Antipyretic and Anti-inflammatory Mechanism of Shuanghuanglian Oral Liquid Based on Gut Microbiota-Host Metabolism. Front Pharmacol 2022;13:843877. [DOI: 10.3389/fphar.2022.843877] [Reference Citation Analysis]
6 Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomed Pharmacother 2022;145:112343. [PMID: 34864312 DOI: 10.1016/j.biopha.2021.112343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Liu Y, Jiang Q, Liu Z, Shen S, Ai J, Zhu Y, Zhou L. Alteration of Gut Microbiota Relates to Metabolic Disorders in Primary Aldosteronism Patients. Front Endocrinol (Lausanne) 2021;12:667951. [PMID: 34484110 DOI: 10.3389/fendo.2021.667951] [Reference Citation Analysis]
8 Smith BJ, Piceno Y, Zydek M, Zhang B, Syriani LA, Terdiman JP, Kassam Z, Ma A, Lynch SV, Pollard KS, El-Nachef N. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Sci Rep 2022;12:5517. [PMID: 35365713 DOI: 10.1038/s41598-022-09307-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ishikawa D, Zhang X, Nomura K, Seki N, Haraikawa M, Haga K, Shibuya T, Kim YG, Nagahara A. A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol. Front Med (Lausanne) 2022;9:779205. [PMID: 35273972 DOI: 10.3389/fmed.2022.779205] [Reference Citation Analysis]
10 Li M, Yang L, Mu C, Sun Y, Gu Y, Chen D, Liu T, Cao H. Gut Microbial Metabolome in Inflammatory Bowel Disease: from Association to Therapeutic Perspectives. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.038] [Reference Citation Analysis]